Abstract
The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T>G; rs2279744) facilitates Sp1 transcription factor binding to the promoter and is associated with increased cancer risk. In contrast, SNP285G>C (rs117039649), located 24 bp upstream of rs2279744, and in complete linkage disequilibrium with the SNP309G allele, reduces Sp1 recruitment and lowers cancer risk. Thus, fine tuning of MDM2 expression has proven to be of significant importance with respect to tumorigenesis. We assessed the potential functional effects of a third MDM2 promoter P2 polymorphism (SNP344T>A; rs1196333) located on the SNP309T allele. While in silico analyses indicated SNP344A to modulate TFAP2A, SPIB and AP1 transcription factor binding, we found no effect of SNP344 status on MDM2 expression levels. Assessing the frequency of SNP344A in healthy Caucasians (n = 2,954) and patients suffering from ovarian (n = 1,927), breast (n = 1,271), endometrial (n = 895) or prostatic cancer (n = 641), we detected no significant difference in ...Continue Reading
References
Jun 26, 1992·Cell·J MomandA J Levine
Jul 2, 1992·Nature·J D OlinerB Vogelstein
Jun 22, 1995·Nature·Z X XiaoD M Livingston
Jan 30, 1997·Oncogene·B Ogretmen, A R Safa
Jul 22, 1998·Nucleic Acids Research·J MomandJ Niland
Mar 7, 2003·Cancer Cell·Rossana TrottaBruno Calabretta
Dec 19, 2003·Nucleic Acids Research·Albin SandelinBoris Lenhard
Nov 20, 2004·Cell·Gareth L BondArnold J Levine
May 19, 2006·Cancer Research·Gareth L BondArnold J Levine
Jul 11, 2006·Journal of Medical Genetics·Gareth L BondArnold J Levine
Dec 11, 2007·Breast Cancer Research : BCR·Matthew J SmalleyAlan Ashworth
Dec 19, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Zhibin HuHongbing Shen
Aug 30, 2008·PloS One·Ranjan ChrisantharPer Eystein Lønning
Jul 11, 2009·Breast Cancer Research and Treatment·Konstantinos P Economopoulos, Theodoros N Sergentanis
Feb 15, 2011·Cancer Cell·Stian KnappskogPer E Lønning
Mar 26, 2011·Oncotarget·Stian Knappskog, Per E Lønning
May 11, 2011·PloS One·Ranjan ChrisantharPer Eystein Lønning
Nov 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stian KnappskogPer E Lønning
Jan 11, 2012·Transcription·Stian Knappskog, Per E Lønning
Jul 26, 2014·Breast Cancer Research and Treatment·Alexandre Bricou, Emmanuel Barranger
Citations
Apr 9, 2014·Infectious Agents and Cancer·Khadija RebbaniSoumaya Benjelloun
Oct 17, 2015·Cancer Medicine·Liv B GansmoPer Eystein Lønning
Aug 22, 2015·BMC Medical Genetics·Kanako OkamotoKiyoko Kato
Sep 15, 2016·Scientific Reports·Reham HelwaStian Knappskog
Jan 3, 2019·PloS One·Johanna M SchuetzAngela R Brooks-Wilson
Sep 21, 2020·Journal of Clinical Laboratory Analysis·Amin JalilvandPantea Mohammadi
Oct 21, 2014·Oncotarget·Stian KnappskogPer E Lønning
Mar 2, 2021·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Reham HelwaStian Knappskog
Apr 24, 2021·Genes & Development·Alyssa M KleinCarol Prives